Overview Performance Dividends Fundamentals Peer Group Correlations Pair Trades Institutions Insider Forecasts Options

BSX - Boston Scientific - Stock Price & Dividends

Exchange: USA Stocks • Country: United States • Currency: USD • Type: Common Stock • ISIN: US1011371077

Medical Devices, Stents, Catheters, Implants, Electrophysiology Systems

Boston Scientific Corporation is a global leader in the development, manufacturing, and marketing of innovative medical devices that improve patient outcomes across various interventional medical specialties.

The company operates through two main segments: MedSurg and Cardiovascular. The MedSurg segment focuses on devices for diagnosing and treating gastrointestinal and pulmonary conditions, such as resolution clips, biliary stent systems, and single-use duodenoscopes. It also offers devices for urological conditions, including ureteral stents, catheters, and holmium laser systems, as well as devices for neurological movement disorders and chronic pain management, such as spinal cord stimulator systems and deep brain stimulation systems.

The Cardiovascular segment, on the other hand, concentrates on technologies for diagnosing and treating coronary artery disease and aortic valve conditions. This includes the WATCHMAN FLX, a Left Atrial Appendage Closure Device, as well as implantable devices that monitor the heart and deliver electricity to treat cardiac abnormalities, such as cardioverter and cardiac resynchronization therapy defibrillators, MRI S-ICD systems, and cardiac resynchronization therapy pacemakers.

In addition to these areas, Boston Scientific Corporation also provides solutions for diagnosing and treating rate and rhythm disorders of the heart, peripheral arterial and venous diseases, and products to diagnose, treat, and ease forms of cancer. With a rich history dating back to 1979, the company is headquartered in Marlborough, Massachusetts, and continues to drive innovation in the medical device industry.

Through its commitment to improving patient lives, Boston Scientific Corporation has established itself as a trusted partner for healthcare professionals and patients worldwide. With a strong focus on research and development, the company is constantly pushing the boundaries of medical technology to address unmet clinical needs and enhance patient outcomes.

Drawdown (Underwater) Chart

Overall Trend and Yearly Seasonality

BSX Stock Overview

Market Cap in USD	115,541m
Sector	Healthcare
Industry	Medical Devices
GiC SubIndustry	Health Care Equipment
TER	0.00%
IPO / Inception	1992-05-18

BSX Stock Ratings

Growth 5y	63.7
Fundamental	49.3
Dividend	0.00
Rel. Performance vs Sector	1.21
Analysts	4.56/5
Fair Price Momentum	76.68 USD
Fair Price DCF	27.85 USD

BSX Dividends

Dividend Yield 12m	0.00%
Yield on Cost 5y	0.00%
Dividends CAGR 5y	0.00%
Payout Consistency	0.0%

BSX Growth Ratios

Growth 12m	44.94%
Growth Correlation 12m	85%
Growth Correlation 3m	64%
CAGR 5y	12.09%
CAGR/Mean DD 5y	1.42
Sharpe Ratio 12m	2.01
Alpha vs SP500 12m	23.49
Beta vs SP500 5y weekly	1.04
ValueRay RSI	7.97
Volatility GJR Garch 1y	20.69%
Price / SMA 50	-1.94%
Price / SMA 200	14.87%
Current Volume	7973.4k
Average Volume 20d	6261.9k

External Links for BSX Stock

News
Wall Street Journal • Benzinga • Yahoo Finance
Tweets
X • Stocktwits
Fund Manager Positions
Dataroma • Stockcircle

What is the price of BSX stocks?
As of July 27, 2024, the stock is trading at USD 74.92 with a total of 7,973,424 shares traded.
Over the past week, the price has changed by -3.40%, over one month by -2.83%, over three months by +2.39% and over the past year by +44.49%.

What are the forecast for BSX stock price target?
According to ValueRays Forecast Model, BSX Boston Scientific will be worth about 84.9 in July 2025. The stock is currently trading at 74.92. This means that the stock has a potential upside of +13.36%.

Issuer	Forecast	Upside
Wallstreet Target Price	84.7	13.1
Analysts Target Price	61.2	-18.3
ValueRay Target Price	84.9	13.4

Boston Scientific Corp: Pioneering Medical Solutions

History and Transformation

Boston Scientific Corporation, founded in 1979, has been at the forefront of the medical devices industry. The journey began with its founders, John Abele and Pete Nicholas, who aimed to provide less invasive, more accessible medical solutions. Boston Scientific distinguished itself early on by introducing groundbreaking medical devices, leading the charge towards less invasive medical treatments globally.

Core Business Focus

At its heart, Boston Scientific is dedicated to transforming lives through innovative medical solutions that improve the health of patients around the world. The company excels in various medical areas, including interventional cardiology, rhythm management, endoscopy, neuromodulation, urology and pelvic health, and peripheral interventions. Boston Scientific's commitment to enhancing patient outcomes through less invasive procedures drives its continuous growth and innovation in these areas.

Expanding Horizons: Side Businesses

Beyond its core products, Boston Scientific has diversified into related healthcare services and solutions, broadening its impact. This includes the development of digital health solutions and services designed to improve patient care, drive efficiencies in healthcare delivery, and offer value beyond their core device offerings. Their involvement in healthcare education for professionals, alongside investments in research and development, signifies a broad-based approach to changing the face of medicine.

Current Market Status

As of the latest market analyses, Boston Scientific Corporation (NYSE:BSX) remains a formidable player in the medical devices sector. The company has shown resilience and adaptability, continuously posting strong financial performance despite challenges posed by global economic changes and the healthcare landscape. Its commitment to innovation, coupled with a strategic approach to market challenges and opportunities, positions Boston Scientific well for future growth.